CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: 15 recruiting locations
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase1, Recruiting
Active & Responsive
A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: 2 recruiting locations
Sponsor: Oncotherapeutics
Sex: All
Age: 0+
Code: NCT06115135
Phase2, Recruiting
Active & Responsive
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
for
Multiple Myeloma
Location: 4 recruiting locations
Sponsor: Canadian Myeloma Research Group
Sex: All
Age: 65+
Code: NCT05272826
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Location: 1 recruiting location
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06822972
Phase2, Recruiting
Active & Responsive
National Cancer Institute "Cancer Moonshot Biobank"
for
Acute Myeloid Leukemia,
Location: 107 recruiting locations
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 13+
Code: NCT04314401
Recruiting
Active & Responsive
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
for
Secondary Progressive Multiple Sclerosis
Location: 7 recruiting locations
Sponsor: Tiziana Life Sciences LTD
Sex: All
Age: 18 - 70+
Code: NCT06292923
Phase2, Recruiting
Active & Responsive
NARCOMS Registry: A Multiple Sclerosis Registry
for
Multiple Sclerosis
Location: 1 recruiting location
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT01018537
Recruiting
Active & Responsive
Examining the Effects of a Remotely-delivered, Racially-tailored Exercise Training Program for Immediate and Sustained Improvements in Walking Dysfunction, Symptoms, and Health-related Quality of Life (HRQOL) Among African-Americans With Multiple Sclerosis (MS) Residing in Rural Environments.